Clinical Trial Update: The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma

View source ↗

Summary

Clinical trial update examining the role of pyruvate kinase M2 (PKM2) in the growth, invasion and drug resistance of bladder urothelial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma of the Bladder

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Bladder Urothelial Carcinoma | Status: UNKNOWN